Company intelligence / Profile preview

Larada Sciences

Salt Lake City, Utah, United Statesliceclinicsofamerica.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Larada Sciences has commercialized the AirAllé™ medical device, FDA-cleared for killing head lice and 99.2% of their eggs in a single treatment using controlled heated air. The company operates the world’s largest network of professional lice treatment clinics under the Lice Clinics of America brand, with over 150–250 locations globally. Clinical results show high efficacy and safety compared to traditional chemical treatments[1][4][6].

Therapeutic areas: Infectious Diseases
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Maxim Group LLC served as investment banker/advisor

Beyond the preview

Go deeper on Larada Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Larada Sciences.

Explore the full profile